Regional rearrangements in chromosome 15q21 cause formation of cryptic promoters for the CYP19 (aromatase) gene.

Production of appropriate quantities of estrogen in various tissues is essential for human physiology. A single gene (CYP19), regulated via tissue-specific promoters, encodes the enzyme aromatase, which catalyzes the key step in estrogen biosynthesis. Aromatase excess syndrome is inherited as autosomal dominant and characterized by high systemic estrogen levels, short stature, prepubertal gynecomastia and testicular failure in males, and premature breast development and uterine pathology in females. The underlying genetic mechanism is poorly understood. Here, we characterize five distinct heterozygous rearrangements responsible for aromatase excess syndrome in three unrelated families and two individuals (nine patients). The constitutively active promoter of one of five ubiquitously expressed genes located within the 11.2 Mb region telomeric to the CYP19 gene in chromosome 15q21 cryptically upregulated aromatase expression in several tissues. Four distinct inversions reversed the transcriptional direction of the promoter of a gene (CGNL1, TMOD3, MAPK6 or TLN2), placing it upstream of the CYP19 coding region in the opposite strand, whereas a deletion moved the promoter of a fifth gene (DMXL2), normally transcribed from the same strand, closer to CYP19. The proximal breakpoints of inversions were located 17-185 kb upstream of the CYP19 coding region. Sequences at the breakpoints suggested that the inversions were caused by intrachromosomal nonhomologous recombination. Splicing the untranslated exon downstream of each promoter onto the identical junction upstream of the translation initiation site created CYP19 mRNA encoding functional aromatase protein. Taken together, small rearrangements may create cryptic promoters that direct inappropriate transcription of CYP19 or other critical genes.

[1]  A. Bockisch,et al.  Gynaecomastia in a patient with a hCG producing giant cell carcinoma of the lung. Case report. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[2]  C. Adamsbaum,et al.  Prepubertal gynecomastia in Peutz-Jeghers syndrome: incomplete penetrance in a familial case and management with an aromatase inhibitor. , 2006, European journal of endocrinology.

[3]  S. Bulun,et al.  Regulation of Aromatase Expression in Estrogen-Responsive Breast and Uterine Disease: From Bench to Treatment , 2005, Pharmacological Reviews.

[4]  S. Bulun,et al.  Estrogen excess associated with novel gain-of-function mutations affecting the aromatase gene. , 2004, The New England journal of medicine.

[5]  J. V. Moran,et al.  Mobile elements and mammalian genome evolution. , 2003, Current opinion in genetics & development.

[6]  Michael Krawczak,et al.  Translocation and gross deletion breakpoints in human inherited disease and cancer II: Potential involvement of repetitive sequence elements in secondary structure formation between DNA ends , 2003, Human mutation.

[7]  Michael Krawczak,et al.  Translocation and gross deletion breakpoints in human inherited disease and cancer I: Nucleotide composition and recombination‐associated motifs , 2003, Human mutation.

[8]  Takashi Suzuki,et al.  The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[9]  D. Russell,et al.  Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings. , 2003, The Journal of clinical endocrinology and metabolism.

[10]  A. Laquérriere,et al.  An oestrogen-producing seminoma responsible for gynaecomastia. , 2003, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[11]  G. Glazko,et al.  Origin of a substantial fraction of human regulatory sequences from transposable elements. , 2003, Trends in genetics : TIG.

[12]  S. Bulun,et al.  Cloning and characterization of a novel endothelial promoter of the human CYP19 (aromatase P450) gene that is up-regulated in breast cancer tissue. , 2002, Molecular endocrinology.

[13]  A. Weiner SINEs and LINEs: the art of biting the hand that feeds you. , 2002, Current opinion in cell biology.

[14]  P. Stankiewicz,et al.  Genome architecture, rearrangements and genomic disorders. , 2002, Trends in genetics : TIG.

[15]  H. Mabuchi,et al.  Two novel types of contiguous gene deletion of the AVPR2 and ARHGAP4 genes in unrelated Japanese kindreds with nephrogenic diabetes insipidus , 2002, Human mutation.

[16]  C. Mendelson,et al.  Identification of the regulatory regions of the human aromatase P450 (CYP19) gene involved in placenta-specific expression , 2001, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  Martin Koš,et al.  0888-8809/01/$03.00/0 Molecular Endocrinology 15(12):2057–2063 Printed in U.S.A. Copyright © 2001 by The Endocrine Society Minireview: Genomic Organization of the Human ER � Gene Promoter Region , 2022 .

[18]  S. Bulun,et al.  A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the Human Genome Project. , 2001, The Journal of clinical endocrinology and metabolism.

[19]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[20]  G. Chrousos,et al.  The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. , 1998, The Journal of clinical endocrinology and metabolism.

[21]  A. Belgorosky,et al.  Testicular steroid biosynthesis in a boy with a large cell calcifying Sertoli cell tumor producing prepubertal gynecomastia , 1995, Steroids.

[22]  S. Bulun,et al.  Feminizing Sertoli Cell Tumors in Boys with Peutz‐Jeghers Syndrome , 1995, The American journal of surgical pathology.

[23]  M Lichten,et al.  Meiosis-induced double-strand break sites determined by yeast chromatin structure. , 1994, Science.

[24]  S. Bulun,et al.  Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads. , 1993, The Journal of clinical endocrinology and metabolism.

[25]  C. Mendelson,et al.  Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. , 1993, The Journal of biological chemistry.

[26]  M. Castro-Magana,,et al.  Male hypogonadism with gynecomastia caused by late-onset deficiency of testicular 17-ketosteroid reductase. , 1993, The New England journal of medicine.

[27]  N. Harada A unique aromatase (P-450AROM) mRNA formed by alternative use of tissue-specific exons 1 in human skin fibroblasts. , 1992, Biochemical and biophysical research communications.

[28]  J. Wilson,et al.  Aromatase mRNA in the extragonadal tissues of chickens with the henny-feathering trait is derived from a distinctive promoter structure that contains a segment of a retroviral long terminal repeat. Functional organization of the Sebright, Leghorn, and Campine aromatase genes. , 1991, The Journal of biological chemistry.

[29]  R. Santen,et al.  An aromatase-producing sex-cord tumor resulting in prepubertal gynecomastia. , 1991, The New England journal of medicine.

[30]  J. Wilson,et al.  The expression of a functional cDNA encoding the chicken cytochrome P-450arom (aromatase) that catalyzes the formation of estrogen from androgen. , 1988, The Journal of biological chemistry.

[31]  C. H. Chang,et al.  Feminizing sex cord tumor with annular tubules in a boy with Peutz-Jeghers syndrome. , 1982, The Journal of pediatrics.

[32]  C. Mendelson,et al.  Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. , 1981, The Journal of clinical endocrinology and metabolism.

[33]  J. Wilson,et al.  pathogenesis of the henny feathering trait in the Sebright bantam chicken. Increased conversion of androgen to estrogen in skin. , 1980, The Journal of clinical investigation.

[34]  J. Wilson,et al.  Origin of estrogen in normal men and in women with testicular feminization. , 1979, The Journal of clinical endocrinology and metabolism.

[35]  J. Marks,et al.  Massive Extraglandular Aromatization of Plasma Androstenedione Resulting in Feminization of a Prepubertal Boy , 1977 .

[36]  R. Dorfman,et al.  FEMINIZING ADRENOCORTICAL TUMORS IN THE MALE: A Review Of 52 Cases Including A Case Report , 1965, Medicine.

[37]  A. Root,et al.  Hetero- and Isosexual Pseudoprecocity Associated with Testicular Sex-Cord Tumors in an 8 Year-Old Male , 1996, Journal of pediatric endocrinology & metabolism : JPEM.